Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Net Cash Flow: 2018-2024

Historic Net Cash Flow for Gossamer Bio (GOSS) over the last 7 years, with Dec 2024 value amounting to $14.1 million.

  • Gossamer Bio's Net Cash Flow rose 70.46% to -$17.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$19.5 million, marking a year-over-year increase of 64.05%. This contributed to the annual value of $14.1 million for FY2024, which is 117.59% up from last year.
  • Gossamer Bio's Net Cash Flow amounted to $14.1 million in FY2024, which was up 117.59% from -$80.0 million recorded in FY2023.
  • Gossamer Bio's 5-year Net Cash Flow high stood at $351.5 million for FY2020, and its period low was -$303.0 million during FY2021.
  • For the 3-year period, Gossamer Bio's Net Cash Flow averaged around -$45.6 million, with its median value being -$71.0 million (2022).
  • Its Net Cash Flow has fluctuated over the past 5 years, first skyrocketed by 1,087.57% in 2020, then tumbled by 186.19% in 2021.
  • Gossamer Bio's Net Cash Flow (Yearly) stood at $351.5 million in 2020, then tumbled by 186.19% to -$303.0 million in 2021, then spiked by 76.57% to -$71.0 million in 2022, then dropped by 12.68% to -$80.0 million in 2023, then soared by 117.59% to $14.1 million in 2024.